C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling

Published:2017-06-26 Issue:9 Volume:38 Page:1257-1268
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Wang Pan-xia,Li Zhuo-ming,Cai Si-dong,Li Jing-yan,He Ping,Huang Yi,Feng Guo-shuai,Luo Hai-bin,Chen Shao-rui,Liu Pei-qing

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201738.pdf

Reference56 articles.

1. Liu R, Molkentin JD . Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs). J Mol Cell Cardiol 2016.

2. Cotecchia S, Del Vescovo CD, Colella M, Caso S, Diviani D . The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications. Cell Signal 2015; 27: 1984–93.

3. Takano H, Zou Y, Akazawa H, Toko H, Mizukami M, Hasegawa H, et al. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy. Hypertens Res 2002; 25: 491–8.

4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–6.

5. Francis SH, Blount MA, Corbin JD . Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol Rev 2011; 91: 651–90.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of phosphodiesterase 9A inhibitors in heart failure;Expert Opinion on Investigational Drugs;2024-05-08

2. Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial;Journal of the American Heart Association;2024-04-02

3. Renal and cardiac effects of the PDE9 inhibitor BAY 73–6691 in 5/6 nephrectomized rats;Pflügers Archiv - European Journal of Physiology;2024-02-02

4. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16

5. Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model;ACS Chemical Neuroscience;2023-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3